Cargando sesión...

Flash session: Tackling the sale of falsified medicines on social media through digital empowerment of providers.

Session Information

As online and social media platforms increasingly serve as conduits for falsified medicines, global stakeholders are advancing innovative responses to curb this threat. This solutions-oriented session will spotlight lessons learned from industry, enforcement, and policy collaborations that have successfully disrupted illicit sales networks. Panelists will discuss real-world case studies, digital investigation approaches, and coordinated actions between the private sector, law enforcement, and public health agencies. The session will highlight practical pathways for building resilient systems that detect, deter, and dismantle the online trade in falsified medicines while protecting vulnerable populations from digital exploitation.

Oct 23, 2025 14:00 - 15:00(America/New_York)
20251023T1400 20251023T1500 America/New_York Flash session: Tackling the sale of falsified medicines on social media through digital empowerment of providers.

As online and social media platforms increasingly serve as conduits for falsified medicines, global stakeholders are advancing innovative responses to curb this threat. This solutions-oriented session will spotlight lessons learned from industry, enforcement, and policy collaborations that have successfully disrupted illicit sales networks. Panelists will discuss real-world case studies, digital investigation approaches, and coordinated actions between the private sector, law enforcement, and public health agencies. The session will highlight practical pathways for building resilient systems that detect, deter, and dismantle the online trade in falsified medicines while protecting vulnerable populations from digital exploitation.

BESAFE2025 besafe@jh.edu
315 visitas

Participantes de la sesión

Usuario en línea
Ponentes, moderadores y asistentes de la sesión
Anticounterfeiting Program Director
,
ANDI - COLOMBIAN NATIONAL BUSSINES ASSOCIATION
VP Global Litigation and Enforcement
,
IP House
Director
,
Johnson & Johnson
National Program Manager
,
National Intellectual Property Rights Coordination Center (IPR Center), U.S. Department of Homeland Security
Vice President, Global PIPS & AMER Security Lead
,
Pfizer
Ningún asistente ha registrado su entrada en esta sesión
8 asistentes guardaron esta sesión

Chat de la sesión

Chat en vivo
Chatea con los participantes que asisten a esta sesión

Preguntas y respuestas

Respondidas
Envía preguntas para los ponentes

Encuestas de la sesión

Activas
Participa en encuestas en vivo

Necesitas ayuda?

Problemas técnicos?

Si tienes problemas de reproducción, prueba a ajustar la calidad o a actualizar la página.

Preguntas para los ponentes?

Usa la pestaña de Preguntas y respuestas para enviar preguntas que podrían abordarse en sesiones de seguimiento.